Furthermore, the expression levels of miR-182-5p, Cyld and Foxo1 detected in liver human samples by using GSE22058 datasets evidenced the miR-182-5p expression increase in hepatic disease progression associated with a concurrent Cyld/Foxo1 level decrease. Here, FOXO1 is linked to liver disorder.